Organ Function Assays - Medical Devices Pipeline Assessment, 2020

Organ Function Assays - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Organ Function Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Organ Function Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Organ Function Assays are the group of tests that reflects distinct organ dysfunction/disease. This category includes kidney, liver, pancreatic and thyroid etc.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Organ Function Assays under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Organ Function Assays under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents2 Introduction

3 Products under Development

3.1 Organ Function Assays - Pipeline Products by Stage of Development
3.2 Organ Function Assays - Pipeline Products by Territory
3.3 Organ Function Assays - Pipeline Products by Regulatory Path
3.4 Organ Function Assays - Pipeline Products by Estimated Approval Date
3.5 Organ Function Assays - Ongoing Clinical Trials

4 Organ Function Assays - Pipeline Products under Development by Companies

4.1 Organ Function Assays Companies - Pipeline Products by Stage of Development
4.2 Organ Function Assays - Pipeline Products by Stage of Development

5 Organ Function Assays Companies and Product Overview

5.1 Boditech Med Inc Company Overview
5.2 China Medical Technologies Inc (Inactive) Company Overview
5.3 Cornell University Company Overview
5.4 Daxor Corp Company Overview
5.5 DSX Therapeutics LLC Company Overview
5.6 French National Institute of Health and Medical Research Company Overview
5.7 HepQuant Llc Company Overview
5.8 Merck Millipore Corp Company Overview
5.9 Myriad Genetics Inc Company Overview
5.10 Proteome Sciences Plc Company Overview
5.11 Radboud University Medical Centre Company Overview
5.12 Schnellgen, Inc Company Overview

6 Organ Function Assays- Recent Developments7 Appendix

List of Tables

Table 1: Organ Function Assays - Pipeline Products by Stage of Development
Table 2: Organ Function Assays - Pipeline Products by Territory
Table 3: Organ Function Assays - Pipeline Products by Regulatory Path
Table 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
Table 5: Organ Function Assays - Ongoing Clinical Trials
Table 6: Organ Function Assays Companies - Pipeline Products by Stage of Development
Table 7: Organ Function Assays - Pipeline Products by Stage of Development
Table 8: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AFIAS-6 - Cystatin C Test - Product Status
Table 10: AFIAS-6 - Cystatin C Test - Product Description
Table 11: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Diagnostic Assay - Alpha 1-Microglobulin - Product Status
Table 13: Diagnostic Assay - Alpha 1-Microglobulin - Product Description
Table 14: Diagnostic Assay - ß2-Microglobulin - Product Status
Table 15: Diagnostic Assay - ß2-Microglobulin - Product Description
Table 16: Diagnostic Assay - Urea Albumin - Product Status
Table 17: Diagnostic Assay - Urea Albumin - Product Description
Table 18: Cornell University Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Diagnostic Test - Kidney Allograft Dysfunction - Product Status
Table 20: Diagnostic Test - Kidney Allograft Dysfunction - Product Description
Table 21: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 22: BVA-100 Glomerular Filtration Rate - Product Status
Table 23: BVA-100 Glomerular Filtration Rate - Product Description
Table 24: DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Diagnostic Test - Transplant And Graft Rejection - Product Status
Table 26: Diagnostic Test - Transplant And Graft Rejection - Product Description
Table 27: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Kidney Transplant Rejection Assay - Product Status
Table 29: Kidney Transplant Rejection Assay - Product Description
Table 30: HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: HepQuant-Dual - Product Status
Table 32: HepQuant-Dual - Product Description
Table 33: HepQuant-FLOW - Product Status
Table 34: HepQuant-FLOW - Product Description
Table 35: HepQuant-SHUNT - Product Status
Table 36: HepQuant-SHUNT - Product Description
Table 37: HepQuant-STAT - Product Status
Table 38: HepQuant-STAT - Product Description
Table 39: HepQuant Llc - Ongoing Clinical Trials Overview
Table 40: HepQuant-Dual - Development of a Reliable Means for Functional Assessment of Liver Performance after the Fontan Operation: Dual Cholate Clearance Assay

List of Figures

Figure 1: Organ Function Assays - Pipeline Products by Stage of Development
Figure 2: Organ Function Assays - Pipeline Products by Territory
Figure 3: Organ Function Assays - Pipeline Products by Regulatory Path
Figure 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
Figure 5: Organ Function Assays - Ongoing Clinical Trials